Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Return on Sales (2024 - 2026)

Rallybio's Return on Sales history spans 2 years, with the latest figure at 0.26% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 253.0% to 0.26% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.09%, a 78.0% increase, with the full-year FY2025 number at 0.09%, up 78.0% from a year prior.
  • Return on Sales hit 0.26% in Q4 2025 for Rallybio, down from 0.76% in the prior quarter.
  • Over the last five years, Return on Sales for RLYB hit a ceiling of 0.76% in Q3 2025 and a floor of 2.79% in Q4 2024.